Nektar Therapeutics (NKTR) Return on Sales [ROS] (2010 - 2026)
Nektar Therapeutics' Return on Sales [ROS] came in at -417.94% for Q2 2026, down 93.73 percentage points from -324.21% a year earlier and down 58.35 percentage points from the prior quarter.
Nektar Therapeutics (NKTR) Return on Sales [ROS] (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Nektar Therapeutics reported Return on Sales [ROS] of -257.80%, down 123.34 percentage points year-over-year; for FY2025, it came in at -253.66%, down 146.78 percentage points from FY2024.
- Return on Sales [ROS] carries a five-year change of +24.34 percentage points (FY2020 to FY2025).
- Going back by year, Return on Sales [ROS] was -106.88% in FY2024 (+185.71 pp), -292.59% in FY2023 (+116.05 pp), -408.63% in FY2022 (+29.12 pp) and -437.76% in FY2021 (-159.75 pp).
- The Q2 2026 figure represents the lowest quarterly Return on Sales [ROS] since Q1 2025.
- Year-over-year, Return on Sales [ROS] increased in three of the last eight quarters, with an average year-over-year change of -58.91 percentage points.
- The fastest year-over-year change in Return on Sales [ROS] over five years came in Q2 2023 (a gain of 461.23 percentage points), and the weakest in Q2 2022 (a drop of 319.06 percentage points).
- Business Quant data shows NKTR's Return on Sales [ROS] at -359.58% (Q1 2026), -126.86% (Q4 2025) and -268.63% (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 52.42% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 30.89% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 32.98% |
| 10 | Nektar Therapeutics | 1.25 Bn | -515.86 Mn | - | -417.94% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -417.94% |
| Mar 31, 2026 | -359.58% |
| Dec 31, 2025 | -126.86% |
| Sep 30, 2025 | -268.63% |
| Jun 30, 2025 | -324.21% |
| Mar 31, 2025 | -425.76% |
| Dec 31, 2024 | 49.18% |
| Sep 30, 2024 | -142.37% |
| Jun 30, 2024 | -211.90% |
| Mar 31, 2024 | -163.72% |
| Dec 31, 2023 | -140.30% |
| Sep 30, 2023 | -185.82% |
| Jun 30, 2023 | -246.84% |
| Mar 31, 2023 | -623.83% |
| Dec 31, 2022 | -238.25% |
| Sep 30, 2022 | -229.85% |
| Jun 30, 2022 | -708.07% |
| Mar 31, 2022 | -469.58% |
| Dec 31, 2021 | -451.48% |
| Sep 30, 2021 | -455.82% |
Nektar Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=NKTR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "NKTR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=NKTR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();